1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine

C90H97N31O7S — CID 159445634

IUPAC1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine
SMILESCOCCn1ccc2cc(N)cc(NCc3ccc(C)cn3)c21.COc1cc(OC)nc(Cn2ccc3cc(N)cc(NCc4noc(C)n4)c32)n1.COc1ccccc1Cn1ccc2nc(N)nc(NCc3ncc(C)s3)c21.Cc1coc(CNc2nc(C)nc3ccn(Cc4ccccn4)c23)n1.Cc1nc(NCc2noc(C)n2)c2c(ccn2Cc2ncccn2)n1
InChIInChI=1S/C19H21N7O3.C19H20N6OS.C18H18N6O.C18H22N4O.C16H16N8O/c1-11-22-15(25-29-11)9-21-14-7-13(20)6-12-4-5-26(19(12)14)10-16-23-17(27-2)8-18(24-16)28-3;1-12-9-21-16(27-12)10-22-18-17-14(23-19(20)24-18)7-8-25(17)11-13-5-3-4-6-15(13)26-2;1-12-11-25-16(21-12)9-20-18-17-15(22-13(2)23-18)6-8-24(17)10-14-5-3-4-7-19-14;1-13-3-4-16(20-11-13)12-21-17-10-15(19)9-14-5-6-22(18(14)17)7-8-23-2;1-10-20-12-4-7-24(9-14-17-5-3-6-18-14)15(12)16(21-10)19-8-13-22-11(2)25-23-13/h4-8,21H,9-10,20H2,1-3H3;3-9H,10-11H2,1-2H3,(H3,20,22,23,24);3-8,11H,9-10H2,1-2H3,(H,20,22,23);3-6,9-11,21H,7-8,12,19H2,1-2H3;3-7H,8-9H2,1-2H3,(H,19,20,21)
InChIKeyLSSMUKUQUJYDLQ-UHFFFAOYSA-N
MW1757.04 g/mol
LogP13.99
Rot. Bonds29

About 1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine

1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine (PubChem CID 159445634) has the molecular formula C90H97N31O7S and a molecular weight of 1757.04 g/mol. Its IUPAC name is 1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine.

Molecular Properties

Compound Name1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine
PubChem CID159445634
Molecular FormulaC90H97N31O7S
Molecular Weight1757.04 g/mol
Exact Mass1755.79
IUPAC Name1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine
SMILESCOCCn1ccc2cc(N)cc(NCc3ccc(C)cn3)c21.COc1cc(OC)nc(Cn2ccc3cc(N)cc(NCc4noc(C)n4)c32)n1.COc1ccccc1Cn1ccc2nc(N)nc(NCc3ncc(C)s3)c21.Cc1coc(CNc2nc(C)nc3ccn(Cc4ccccn4)c23)n1.Cc1nc(NCc2noc(C)n2)c2c(ccn2Cc2ncccn2)n1
InChIInChI=1S/C19H21N7O3.C19H20N6OS.C18H18N6O.C18H22N4O.C16H16N8O/c1-11-22-15(25-29-11)9-21-14-7-13(20)6-12-4-5-26(19(12)14)10-16-23-17(27-2)8-18(24-16)28-3;1-12-9-21-16(27-12)10-22-18-17-14(23-19(20)24-18)7-8-25(17)11-13-5-3-4-6-15(13)26-2;1-12-11-25-16(21-12)9-20-18-17-15(22-13(2)23-18)6-8-24(17)10-14-5-3-4-7-19-14;1-13-3-4-16(20-11-13)12-21-17-10-15(19)9-14-5-6-22(18(14)17)7-8-23-2;1-10-20-12-4-7-24(9-14-17-5-3-6-18-14)15(12)16(21-10)19-8-13-22-11(2)25-23-13/h4-8,21H,9-10,20H2,1-3H3;3-9H,10-11H2,1-2H3,(H3,20,22,23,24);3-8,11H,9-10H2,1-2H3,(H,20,22,23);3-6,9-11,21H,7-8,12,19H2,1-2H3;3-7H,8-9H2,1-2H3,(H,19,20,21)
InChIKeyLSSMUKUQUJYDLQ-UHFFFAOYSA-N
XLogP13.99
TPSA471.22 Ų
H-Bond Donors8
H-Bond Acceptors39
Rotatable Bonds29
Heavy Atoms129
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001757.04
LogP ≤ 513.99
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1039

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze 1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine?
The IUPAC name of 1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine (CID 159445634) is 1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine.
What is the SMILES notation for 1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine?
The canonical SMILES for 1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine is COCCn1ccc2cc(N)cc(NCc3ccc(C)cn3)c21.COc1cc(OC)nc(Cn2ccc3cc(N)cc(NCc4noc(C)n4)c32)n1.COc1ccccc1Cn1ccc2nc(N)nc(NCc3ncc(C)s3)c21.Cc1coc(CNc2nc(C)nc3ccn(Cc4ccccn4)c23)n1.Cc1nc(NCc2noc(C)n2)c2c(ccn2Cc2ncccn2)n1.
What is the InChIKey of 1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine?
The InChIKey is LSSMUKUQUJYDLQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H21N7O3.C19H20N6OS.C18H18N6O.C18H22N4O.C16H16N8O/c1-11-22-15(25-29-11)9-21-14-7-13(20)6-12-4-5-26(19(12)14)10-16-23-17(27-2)8-18(24-16)28-3;1-12-9-21-16(27-12)10-22-18-17-14(23-19(20)24-18)7-8-25(17)11-13-5-3-4-6-15(13)26-2;1-12-11-25-16(21-12)9-20-18-17-15(22-13(2)23-18)6-8-24(17)10-14-5-3-4-7-19-14;1-13-3-4-16(20-11-13)12-21-17-10-15(19)9-14-5-6-22(18(14)17)7-8-23-2;1-10-20-12-4-7-24(9-14-17-5-3-6-18-14)15(12)16(21-10)19-8-13-22-11(2)25-23-13/h4-8,21H,9-10,20H2,1-3H3;3-9H,10-11H2,1-2H3,(H3,20,22,23,24);3-8,11H,9-10H2,1-2H3,(H,20,22,23);3-6,9-11,21H,7-8,12,19H2,1-2H3;3-7H,8-9H2,1-2H3,(H,19,20,21).
What are the key properties of 1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine?
1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine has a molecular weight of 1757.04 g/mol, XLogP of 13.99, 29 rotatable bonds, 8 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(4,6-dimethoxypyrimidin-2-yl)methyl]-7-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]indole-5,7-diamine;1-(2-methoxyethyl)-7-N-[(5-methyl-2-pyridinyl)methyl]indole-5,7-diamine;5-[(2-methoxyphenyl)methyl]-4-N-[(5-methyl-1,3-thiazol-2-yl)methyl]pyrrolo[3,2-d]pyrimidine-2,4-diamine;2-methyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrimidin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine;2-methyl-N-[(4-methyl-1,3-oxazol-2-yl)methyl]-5-(pyridin-2-ylmethyl)pyrrolo[3,2-d]pyrimidin-4-amine is sourced from PubChem (CID 159445634), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).